A critical review of the diagnosis and management of Barrett’s esophagus: the AGA Chicago Workshop1 1Members of the workshop composed a group of international experts in BE from gastroenterology, surgery, pathology, molecular biology, outcomes, and epidemiology. Conference chairman: Prateek Sharma; conference moderator: Kenneth McQuaid; group leaders: John Dent, M. Brian Fennerty, Richard Sampliner, Stuart Spechler; participants: Alan Cameron, Douglas Corley, Gary Falk, John Goldblum, John Hunter, Janusz Jankowski, Lars Lundell, Brian Reid, Nicholas Shaheen, Amnon Sonnenberg, Kenneth Wang, and Wilfred Weinstein.Prateek Sharma, Wilfred M. Weinstein, John R. Goldblum et al.|Gastroenterology|2004Cited by 526
Consensus Statements for Management of Barrett's Dysplasia and Early-Stage Esophageal Adenocarcinoma, Based on a Delphi ProcessCathy Bennett, David Poller, Nimish Vakil et al.|Gastroenterology|2012Cited by 378
Seven-year follow-up of a randomized clinical trial comparing proton-pump inhibition with surgical therapy for reflux oesophagitisLars Lundell, A. Walan, Pekka Miettinen et al.|British journal of surgery|2007Cited by 171
Comparison of Outcomes Twelve Years After Antireflux Surgery or Omeprazole Maintenance Therapy for Reflux EsophagitisLars Lundell, A. Walan, Pekka Miettinen et al.|Clinical Gastroenterology and Hepatology|2009Cited by 150
Changes of gastric mucosal architecture during long‐term omeprazole therapy: results of a randomized clinical trialLars Lundell, Niilo Havu, Pekka Miettinen et al.|Alimentary Pharmacology & Therapeutics|2006Cited by 89